News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,069 Results
Type
Article (1938)
Company Profile (2)
Press Release (67129)
Section
Business (21529)
Career Advice (9)
Deals (4573)
Drug Development (8218)
FDA (1813)
Job Trends (802)
News (37167)
Policy (3573)
Tag
Academia (91)
Alliances (8088)
Alzheimer's disease (114)
Approvals (1818)
Artificial intelligence (6)
Bankruptcy (9)
Best Places to Work (580)
Biosimilars (10)
Biotechnology (5)
Breast cancer (9)
Cancer (108)
Career advice (9)
Cell therapy (11)
Clinical research (6914)
Collaboration (38)
COVID-19 (177)
C-suite (6)
Data (104)
Diabetes (9)
Diagnostics (587)
Drug discovery (7)
Duchenne muscular dystrophy (6)
Earnings (7523)
Events (6861)
Executive appointments (24)
FDA (1876)
Funding (27)
Gene therapy (8)
GLP-1 (38)
Government (234)
Healthcare (1082)
Infectious disease (180)
Inflammatory bowel disease (13)
IPO (1622)
Job creations (240)
Job search strategy (9)
Layoffs (7)
Legal (944)
Liver cancer (15)
Lung cancer (21)
Lymphoma (4)
Manufacturing (13)
Medical device (1109)
Medtech (1110)
Mergers & acquisitions (2988)
Metabolic disorders (24)
Neuroscience (137)
NextGen Class of 2024 (219)
Non-profit (62)
Northern California (91)
Obesity (9)
Pancreatic cancer (4)
Parkinson's disease (8)
Patents (9)
People (4924)
Phase I (1861)
Phase II (2881)
Phase III (2647)
Pipeline (47)
Postmarket research (241)
Preclinical (653)
Radiopharmaceuticals (21)
Rare diseases (14)
Real estate (599)
Regulatory (2524)
Reports (6)
Research institute (93)
Schizophrenia (4)
Series A (7)
Southern California (74)
Startups (422)
Supply chain (4)
United States (723)
Vaccines (17)
Date
Today (11)
Last 7 days (70)
Last 30 days (302)
Last 365 days (3342)
2024 (3010)
2023 (3825)
2022 (7026)
2021 (6387)
2020 (5892)
2019 (3892)
2018 (3029)
2017 (3604)
2016 (3219)
2015 (4055)
2014 (3022)
2013 (2602)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (79)
Arizona (5)
Asia (21094)
Australia (2412)
California (187)
Canada (149)
China (76)
Connecticut (7)
Europe (12349)
Florida (9)
Illinois (10)
Japan (29)
Kansas (5)
Maryland (58)
Massachusetts (140)
Minnesota (19)
New Jersey (87)
New York (76)
North Carolina (45)
Northern California (91)
Pennsylvania (29)
South America (105)
Southern California (74)
Texas (10)
Utah (6)
Virginia (8)
69,069 Results for "novocure ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novocure to Report Second Quarter 2024 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open.
July 1, 2024
·
3 min read
FDA
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
October 15, 2024
·
11 min read
Press Releases
Novocure Appoints Christoph Brackmann as Chief Financial Officer
October 30, 2024
·
4 min read
Press Releases
Novocure Reports Third Quarter 2024 Financial Results
October 30, 2024
·
11 min read
Business
Novocure Reports First Quarter 2024 Financial Results
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2024.
May 2, 2024
·
10 min read
Press Releases
Novocure to Report Third Quarter 2024 Financial Results
October 1, 2024
·
3 min read
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP.
May 2, 2024
·
4 min read
Drug Development
Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer
Novocure’s stock spiked more than 15% Wednesday morning after the company announced its Tumor Treating Fields therapy met the primary endpoint in a late-stage trial.
March 27, 2024
·
3 min read
·
Tyler Patchen
Drug Development
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
Novocure (NASDAQ: NVCR) today announced the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer (NSCLC) will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, to be held from May 31 to June 4.
April 24, 2024
·
7 min read
Business
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2023.
February 22, 2024
·
12 min read
1 of 6,907
Next
